Literature DB >> 10652915

Value of the dynamic and delayed MR sequence with Gd-DTPA in the T-staging of stomach cancer: correlation with the histopathology.

B C Kang1, J H Kim, K W Kim, D Y Lee, S Y Baek, S W Lee, W H Jung.   

Abstract

BACKGROUND: To evaluate the usefulness of dynamic and delayed magnetic resonance (MR) imaging in the T-staging of stomach cancer and to compare the enhancement pattern of the cancerous lesion and the normal wall.
METHODS: We performed MR imaging in 46 patients with stomach cancer (including four early gastric cancers and 42 advanced gastric cancers). Axial, sagittal, or coronal two-dimensional fast low-angle shot) MR images for the water-distended stomach were obtained with dynamic protocol, including precontrast images and images obtained 30, 60, 90, and 240-300 s after intravenous injection of the 0.1 mM Gd-DTPA/kg solution. We evaluated the thickness, interruption (or not) of the low signal intensity bands, and enhancement pattern of the cancerous wall and normal gastric wall. We prospectively evaluated the depth of cancer invasion, perigastric infiltration (extraserosal invasion), perigastric organ invasion, and regional lymph nodes and determined tumor staging on MR images. These MR evaluations including MR-determined staging were correlated with the surgicopathologic findings.
RESULTS: Stomach cancer was shown as having a thickened wall with a rapid enhancing pattern after intravenous Gd-DTPA administration. The mucosa (and/or submucosa) affected by stomach cancer showed an early enhancement pattern (30-90 s after Gd-DTPA administration) in 43 of 46 patients (93%). The normal gastric mucosa demonstrated a delayed peak enhancement pattern (> 90 s after Gd-DTPA administration) in 29 of 46 patients (63%) and variable enhancement pattern in 17 of 46 patients (37%). An interrupted low signal intensity band or highly enhanced tumorous lesion penetrating through the gastric wall was seen in 17 of 19 pT3 patients (90%). Consistency between MR-determined staging and surgicopathologic staging occurred in three of four pT1 tumors (75%), 10 of 13 pT2 tumors (77%), 17 of 19 pT3 tumors (90%), and eight of 10 pT4 tumors (80%); overall accuracy was 83%. Overall accuracy of regional lymph node involvement, as determined by enhanced MR, was 52%; 24 of 46 node groups were positive.
CONCLUSIONS: Dynamic and delayed MR imaging can be useful for predicting depth of cancer invasion, perigastric infiltration (extraserosal invasion), and perigastric organ invasion by gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10652915     DOI: 10.1007/s002619910003

Source DB:  PubMed          Journal:  Abdom Imaging        ISSN: 0942-8925


  17 in total

Review 1.  Imaging in assessing lymph node status in gastric cancer.

Authors:  Robert Michael Kwee; Thomas Christian Kwee
Journal:  Gastric Cancer       Date:  2009-04-24       Impact factor: 7.370

Review 2.  Is endoscopic ultrasonography still the modality of choice in preoperative staging of gastric cancer?

Authors:  Sung Wook Hwang; Dong Ho Lee
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

3.  Preoperative locoregional staging of gastric cancer: is there a place for magnetic resonance imaging? Prospective comparison with EUS and multidetector computed tomography.

Authors:  Francesco Giganti; Elena Orsenigo; Paolo Giorgio Arcidiacono; Roberto Nicoletti; Luca Albarello; Alessandro Ambrosi; Annalaura Salerno; Antonio Esposito; Maria Chiara Petrone; Damiano Chiari; Carlo Staudacher; Alessandro Del Maschio; Francesco De Cobelli
Journal:  Gastric Cancer       Date:  2015-01-23       Impact factor: 7.370

Review 4.  Imaging strategies in the management of gastric cancer: current role and future potential of MRI.

Authors:  Alicia S Borggreve; Lucas Goense; Hylke J F Brenkman; Stella Mook; Gert J Meijer; Frank J Wessels; Marcel Verheij; Edwin P M Jansen; Richard van Hillegersberg; Peter S N van Rossum; Jelle P Ruurda
Journal:  Br J Radiol       Date:  2019-03-05       Impact factor: 3.039

Review 5.  State-of-the-art preoperative staging of gastric cancer by MDCT and magnetic resonance imaging.

Authors:  Joon-Il Choi; Ijin Joo; Jeong Min Lee
Journal:  World J Gastroenterol       Date:  2014-04-28       Impact factor: 5.742

6.  The role of ¹⁸F-FDG PET/CT in the assessment of suspected recurrent gastric cancer after initial surgical resection: can the results of FDG PET/CT influence patients' treatment decision making?

Authors:  Ahmet Bilici; Bala Basak Oven Ustaalioglu; Mesut Seker; Umut Kefeli; Nesrin Canpolat; Bulent Tekinsoy; Sule Ozugur; Mahmut Gumus
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-09-14       Impact factor: 9.236

Review 7.  The utility of MRI for pre-operative T and N staging of gastric carcinoma: a systematic review and meta-analysis.

Authors:  Z Huang; D H Xie; L Guo; C H Hu; X Fang; Q Meng; X X Ping; Z W Lu
Journal:  Br J Radiol       Date:  2015-03-19       Impact factor: 3.039

8.  Diagnostic performance of 64-MDCT and 1.5-T MRI with high-resolution sequences in the T staging of gastric cancer: a comparative analysis with histopathology.

Authors:  M Anzidei; A Napoli; F Zaccagna; P Di Paolo; C Zini; B Cavallo Marincola; D Geiger; C Catalano; R Passariello
Journal:  Radiol Med       Date:  2009-09-22       Impact factor: 3.469

9.  Clinical role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in post-operative follow up of gastric cancer: initial results.

Authors:  Long Sun; Xin-Hui Su; Yong-Song Guan; Wei-Ming Pan; Zuo-Ming Luo; Ji-Hong Wei; Hua Wu
Journal:  World J Gastroenterol       Date:  2008-08-07       Impact factor: 5.742

Review 10.  The role of MRI in the diagnosis and treatment of gastric cancer.

Authors:  Yingjing Zhang; Jianchun Yu
Journal:  Diagn Interv Radiol       Date:  2020-05       Impact factor: 2.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.